.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
US Department of Justice
US Army
Argus Health
Boehringer Ingelheim
Deloitte
Healthtrust
Citi
Federal Trade Commission
Chubb

Generated: September 19, 2017

DrugPatentWatch Database Preview

Progesterone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for progesterone and what is the scope of progesterone patent protection?

Progesterone
is the generic ingredient in five branded drugs marketed by Bionpharma Inc, Dr Reddys Labs Inc, Allergan Sales Llc, Fresenius Kabi Usa, Teva Pharms, Amneal Pharms Ny, Hikma Farmaceutica, Lilly, Luitpold, Alza, Sofgen Pharms, Ferring, Actavis Labs Ut Inc, and Virtus Pharms, and is included in fourteen NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Progesterone has eleven patent family members in nine countries.

There are fifty-two drug master file entries for progesterone. Twenty-four suppliers are listed for this compound.

Summary for Generic Name: progesterone

Tradenames:5
Patents:3
Applicants:14
NDAs:14
Drug Master File Entries: see list52
Suppliers / Packagers: see list24
Bulk Api Vendors: see list76
Clinical Trials: see list740
Patent Applications: see list9,870
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:progesterone at DailyMed

Pharmacology for Ingredient: progesterone

Ingredient-typeProgesterone
Drug ClassProgesterone
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Ny
PROGESTERONE
progesterone
CAPSULE;ORAL207724-002Sep 7, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Sofgen Pharms
PROGESTERONE
progesterone
CAPSULE;ORAL200456-002Sep 28, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Bionpharma Inc
PROGESTERONE
progesterone
CAPSULE;ORAL200900-002Aug 16, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Ferring
ENDOMETRIN
progesterone
INSERT;VAGINAL022057-001Jun 21, 2007RXYesYes► Subscribe► Subscribe ► Subscribe
Alza
PROGESTASERT
progesterone
INSERT, EXTENDED RELEASE;INTRAUTERINE017553-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
PROGESTERONE
progesterone
INJECTABLE;INJECTION009238-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ferring
ENDOMETRIN
progesterone
INSERT;VAGINAL022057-001Jun 21, 2007RXYesYes► Subscribe► Subscribe ► Subscribe
Virtus Pharms
PROMETRIUM
progesterone
CAPSULE;ORAL019781-003Oct 15, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Hikma Farmaceutica
PROGESTERONE
progesterone
INJECTABLE;INJECTION091033-001Oct 28, 2010AORXNoNo► Subscribe► Subscribe► Subscribe
Ferring
ENDOMETRIN
progesterone
INSERT;VAGINAL022057-001Jun 21, 2007RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: progesterone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan Sales Llc
CRINONE
progesterone
GEL;VAGINAL020701-001Jul 31, 1997► Subscribe► Subscribe
Allergan Sales Llc
CRINONE
progesterone
GEL;VAGINAL020701-002Jul 31, 1997► Subscribe► Subscribe
Allergan Sales Llc
CRINONE
progesterone
GEL;VAGINAL020701-002Jul 31, 1997► Subscribe► Subscribe
Allergan Sales Llc
CRINONE
progesterone
GEL;VAGINAL020701-001Jul 31, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: progesterone

Country Document Number Estimated Expiration
Japan2011026335► Subscribe
World Intellectual Property Organization (WIPO)0028970► Subscribe
Denmark1131052► Subscribe
Spain2390959► Subscribe
TaiwanI239249► Subscribe
Japan2002529494► Subscribe
European Patent Office1131052► Subscribe
Australia1176200► Subscribe
Japan4667601► Subscribe
Canada2568823► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: PROGESTERONE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0037Belgium► SubscribePRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Teva
McKinsey
Fish and Richardson
US Army
Cipla
Cantor Fitzgerald
Covington
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot